ADS Kellion award 2019
Professor Alicia Jenkins was awarded the ADS Kellion Award 2019
which is The Australian Diabetes Society’s most prestigious award given to someone who has made an outstanding contribution in diabetes research, clinical or service areas in Australia.
Professor Jenkins is a clinical endocrinologist and lipidologist, focusing on Type 1 and Type 2 diabetes and their associated microvascular and macrovascular complications at St. Vincent’s Hospital Melbourne
Professor Jenkins has a high profile nationally and internationally for her research into the prediction and prevention and underlying mechanisms of diabetes complications and in the use of frontier technologies in diabetes care, including insulin pumps, continuous glucose monitors and telehealth. With over 25 years of research experience she leads both clinical and basic science research groups exploring diabetes and its complications, pre-diabetes, beta cell biology, circulating and tissue biomarkers, vascular imaging and telehealth.
Professor Jenkins is unique in having skills in basic sciences (cell and molecular biology – including genetics, epigenetics and the gut microbiome – and animal models), clinical medicine, clinical trials research and translation of evidence into practice in the specialty areas of adult and paediatric diabetes, lipids, biomarkers and cardiovascular disease.
Her clinical practice relates predominantly to Type 1 diabetes care from youth to old age, including insulin pump and glucose sensor use.
Dr Jenkins interacts with several diabetes interest groups, Diabetes Australia and is on the board of two international diabetes aid programs
(Insulin For Life and IDF / Life For a Child).
She gives community talks regarding diabetes and cardiovascular disease to various service clubs.
ADS Kellion award 2019
Professor Alicia Jenkins was awarded the ADS Kellion Award 2019 which is The Australian Diabetes Society’s most prestigious award given to someone who has made an outstanding contribution in diabetes research, clinical or service areas in Australia.
Professor Jenkins is a clinical endocrinologist and lipidologist, focusing on Type 1 and Type 2 diabetes and their associated microvascular and macrovascular complications at St. Vincent’s Hospital Melbourne
Professor Jenkins has a high profile nationally and internationally for her research into the prediction and prevention and underlying mechanisms of diabetes complications and in the use of frontier technologies in diabetes care, including insulin pumps, continuous glucose monitors and telehealth. With over 25 years of research experience she leads both clinical and basic science research groups exploring diabetes and its complications, pre-diabetes, beta cell biology, circulating and tissue biomarkers, vascular imaging and telehealth.
Professor Jenkins is unique in having skills in basic sciences (cell and molecular biology – including genetics, epigenetics and the gut microbiome – and animal models), clinical medicine, clinical trials research and translation of evidence into practice in the specialty areas of adult and paediatric diabetes, lipids, biomarkers and cardiovascular disease.
Her clinical practice relates predominantly to Type 1 diabetes care from youth to old age, including insulin pump and glucose sensor use.
Dr Jenkins interacts with several diabetes interest groups, Diabetes Australia and is on the board of two international diabetes aid programs
(Insulin For Life and IDF / Life For a Child).
She gives community talks regarding diabetes and cardiovascular disease to various service clubs.